The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60.

The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by ...

A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...

U.S. President Donald Trump's nominee for director of the CDC was pulled into political contention over U.S. vaccine policy ...

At the start of an unprecedented meeting of vaccine committee of the US Centers for Disease Control and Prevention, the ...

Brad Pitt Says His Generation of Actors Were ‘More Uptight': ‘You Didn't Sell Out' with Franchises Women cyclists speak out ...

A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.

The CDC's vaccine advisory committee voted to recommend annual flu vaccines but against flu shots containing the preservative thimerosal ...